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Normal term and spontaneous preterm births (PTB) are documented to be associated
with oxidative stress (OS), and imbalances in the redox system (balance between pro- and
antioxidant) have been reported in the maternal–fetal intrauterine compartments.The exact
mechanism of labor initiation either at term or preterm by OS is still unclear, and this lack
of understanding can partially be blamed for failure of antioxidant supplementation trials in
PTB prevention. Based on recent findings from our laboratory, we postulate heterogeneity
in host OS response. The physiologic (at term) and pathophysiologic (preterm) pathways
of labor are not mediated by OS alone but by OS-induced damage to intrauterine tissues,
especially fetal membranes of the placenta. OS damage affects all major cellular elements
in the fetal cells, and this damage promotes fetal cell senescence (aging).The aging of the
fetal cells is predominated by p38 mitogen activated kinase (p38MAPK) pathways. Senesc-
ing cells generate biomolecular signals that are uterotonic, triggering labor process. The
aging of fetal cells is normal at term. However, aging is premature in PTB, especially in
those PTBs complicated by preterm premature rupture of the membranes, where ele-
ments of redox imbalances and OS damage are more dominant. We postulate that fetal
cell senescence signals generated by OS damage are likely triggers for labor. This review
highlights the mechanisms involved in senescence development at term and preterm by
OS damage and provides insight into novel fetal signals of labor initiation pathways.
Keywords: oxidative stress, preterm birth, premature rupture of fetal membranes, inflammation, oxidative damage,
senescence, senescence-associated secretory phenotype
The World Health Organization recently estimated the global
preterm birth (PTB) rate for singleton gestation at 9.6% (1). The
PTB rate has increased in the United States by as much as 30%
during the last 25 years despite advances in medical care (1, 2).
Twenty-eight percent of all neonatal deaths (deaths within the first
7 days of life) that are not related to congenital malformations are
due to PTB (1, 2). The most common phenotype of PTB is spon-
taneous PTB of unknown etiology. Approximately 60% of PTBs
are spontaneous, and 30–40% of these are preceded by preterm
premature rupture of the fetal membranes (pPROM) (3–10). The
current management of preterm labor and pPROM is based largely
on inhibiting uterine contractions (7, 11–25). This approach has
not been successful, as such interventions are usually performed
too late in the process to succeed. A second problem with the cur-
rent management of preterm labor is that only women who have
clear risk factors (abnormally short cervixes) or a history of PTBs
are targeted for interventions designed to prevent PTB (26–30).
The vast majority of PTBs occur in women who are considered
low-risk because they are either on their first pregnancies or have
only had term births previously (31–37). Although the rate of PTB
is lower in these women (3–5%), they make up the largest volume
of clinical practice. Simple interventions that can be applied to this
group are likely to have the largest impact on PTB rates. Knowl-
edge gaps in current literature about causality and causally linked
pathways make it difficult to provide appropriate or personalize
interventions based on the specific risk profile of an individual (6).
Risk factors of PTB and pPROM can be classified into two
major categories, static and dynamic. As shown in Figure 1, all
the risk factors outlined in the outermost layer can be called static
risk factors as they are unlikely to change during the course of
pregnancy. Independently or in combination, these static risk fac-
tors can either predispose or cause the dynamic risk factors that
are commonly diagnosed as clinical risks or pathologies associ-
ated with adverse pregnancy outcomes. Epigenetic changes that
are independent of DNA base variations generated by complex
interactions between various risk factors during pregnancy can
also contribute to dynamic clinical risks by altering expression
of certain genes. These changes can transition between static and
dynamic risks. Static and dynamic risk factors produce pathways
and pathophysiologies depicted in the inner circle with a unique
biomarker profile contributing to labor-inducing changes, result-
ing in PTB or pPROM. The final effector pathways culminating
in labor and delivery include inflammation and oxidative stress
(OS). In normal pregnancies, these are generated by various fetal
and maternal factors that signal the end of pregnancy. In PTB, the
maternal–fetal signals and their causal origins are still unclear as
they arise from complex etiologies and redundant pathways.
Inflammation is a well-studied pathophysiology of both PTB
and pPROM (38–40). This review is an attempt to shed some
light on one of the under-studied mechanistic pathways: OS dam-
age to intrauterine tissues and how it may impact pregnancy
outcomes.
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FIGURE 1 | As depicted in this figure, preterm labor (the innermost
circle) is an end result of multitudes of complex interacting pathologies
and pathophysiologic pathways. The external layer (the outermost circle)
shows static risk factors, including epidemiologic and genetic risk factors,
that can lead to multiple disease processes as depicted in the middle circle.
Epigenetic markers can be dynamic, and that complex interaction between
the host environment and risk factors can produce epigenetic changes,
which can lead to diseases contributing to final effecter pathways (the blue
shaded area). Various diseases may also cause epigenetic changes in the
genes of preterm labor pathways. Spontaneous preterm labor leading to
preterm birth is a complex syndrome comprising multiple diseases, each of
which can be independent initiators of labor-inducing pathways. All these
disease processes can trigger inflammation and oxidative stress (OS).
However, the extent and biomolecular characteristics of inflammation and
OS are dependent on the type of risk that initiated the process, their
complex interactions with the genetic–epigenetic system, and the disease
that they cause. The final terminal pathways that involve inflammation and
OS trigger labor-inducing signals from fetal membranes and decidua and
cause cervical ripening, myometrial contractions, and membrane rupture,
resulting in preterm labor and delivery. *Any exogenous factor that can
impact pregnancy outcomes. Many of the static risk factors in the outer
circles are also called environments.
INFLAMMATION, A WELL-DOCUMENTED FEATURE OF
LABOR AND DELIVERY
Labor and delivery at term and preterm have an underlying
pathophysiology marked by inflammatory mediators. Preterm
labor is hypothesized to be driven by overwhelming inflam-
mation that eclipses fetal uterotonic signals of organ matu-
rity. Approximately 50% of PTBs and 70% of pPROMs are
associated with intra-amniotic infection (IAI) and inflamma-
tion. Histological and microbiological findings indicate that focal
infection and inflammation may play a significant role in the
pathogenesis of PTB and pPROM. Inflammatory changes that
precede PTB – such as leukocyte activation, increased inflam-
matory cytokines and chemokines, and collagenolysis of the
extracellular matrix metalloproteinases (MMPs), resulting in loss
of membrane structural integrity, myometrial activation, and
cervical ripening – are well documented by various experi-
mental and clinical studies (9, 38, 41). Recent studies have
reported that the heterogeneity in the inflammatory response
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(cytokines/chemokines, toll-like-receptors, and their interactions)
is associated with IAI and PTB risk factors (42–45). PTB and
pPROM are well-documented host response diseases in which
overwhelming immune activation can trigger labor-associated
changes. The biomolecular markers that trigger labor-associated
changes are different, and the difference is attributed to both
epidemiologic and clinical risk factors.
SIGNIFICANCE OF OS AND OXIDATIVE DAMAGE
Of these risk factors, IAI, behavioral factors (cigarette smoking,
alcohol intake,and drug use),obesity,malnutrition or antioxidant-
deficient diets, physiologic and psycho-social stressors, environ-
mental pollutants, genotoxic agents, and geographic location are
some of the most common and well-studied risk factors of both
PTB and pPROM (3, 10). The role of inflammation induced by
these risk factors in PTB pathophysiology is well studied and mul-
tiple biomarkers are reported to be associated with the adverse out-
come. OS, characterized by generation of reactive oxygen species
(ROS), is an inseparable component of inflammation. Genera-
tion of ROS as a part of the aerobic energy building process is
inevitable and is well balanced (redox status) by an array of enzy-
matic and non-enzymatic antioxidant systems (46–50). Redox
balance is maintained through the production and subsequent
elimination of ROS. Cells are able to protect themselves against
OS by the finely tuned regulation of redox status through endoge-
nous enzymes, antioxidants, and other cellular mechanisms. At
low levels, ROS, often generated in biological systems, is essen-
tial for cell division and survival, cell signaling, inflammation and
immune functions, autophagy, and stress response (50–52). How-
ever, an overwhelming redox imbalance compromises a biological
system’s ability to detoxify these highly reactive molecules or to
repair any damage caused by them (53). Therefore, the former is
termed “OS” and the latter “oxidative damage” (see Glossary) (54).
Oxidative damage due to ROS generation has been linked to the
development of adult diseases, including cardiovascular disease,
cancer, chronic inflammation, and neurologic disorders. The two
main sources of ROS in human cells are: (1) mitochondrial and
(2) non-mitochondrial. Mitochondria generate ROS as a byprod-
uct of the electron transport chain during respiration, and the rate
of ROS production is proportional to the rate of mitochondrial
respiration. The ROS production rate is thus higher when meta-
bolic rates are high (55, 56). A vast majority of ROS in the human
body is produced by mitochondria, and mitochondria are the pri-
mary sources of superoxide production other than phagocytic cells
during innate immune defense.
Figure 2 depicts the mechanism of ROS generation, antioxidant
system, and potential damage by ROS that can cause damage dur-
ing pregnancy complications. The figure also models the potential
of ROS in generating inflammation and damage to cellular ele-
ments that can generate pathways leading to pPROM or PTB. This
figure represents only a few key mediators of ROS generation and
does not include all known endogenous antioxidants.
FIGURE 2 | A model of reactive oxygen production, its inactivation by
antioxidant systems, and potential consequences of redox imbalances.
Superoxide radicals are generated during normal cellular respiration
(mitochondrial) and also during infection following phagocytosis.
Non-enzymatic and enzymatic mechanisms generate super oxide radicals
(O2− from O2) that are converted into H2O2 by superoxide-dismutase (SOD).
H2O2, a reactive oxygen species (ROS), is reduced to water by several
different enzymes, mainly by catalase. Hydroxyl and/or superoxide radicals are
created from H2O2 by a Fenton reaction that includes Fe3+. H2O2 is a potential
transactivator and can activate a master transcription factor NF-κB, resulting in
activation of several proinflammatory genes including many uterotonic genes.
The Hydroxyl and/or superoxide radicals can cause DNA, protein, and lipid
damage. DNA damage as detailed in this review can lead to telomere
reduction and senescence. DNA damage of the cell can also cause apoptosis.
One of the transactivator proteins is a nuclear factor of erythroid 2-related
factor 2 (Nrf2). When activated in response to ROS, this protein can
transactivate Hemeoxygenase-1 that can also neutralize H2O2, providing a
regulatory mechanism. Our studies have shown that Nrf2 can cause
anti-inflammatory PPAR-γ activation. Depending on the dose and type of
ROS, inflammatory and/or anti-inflammatory/antioxidant pathways may be
initiated. This model shows that OS-associated pathologic events result in
spontaneous preterm birth and pPROM. This is not a universal model for all
OS-related pathologies. Damage to cellular elements has been well
documented in cancers and other diseases.
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HETEROGENEITY IN ANTIOXIDANT FUNCTIONS
Generation of ROS is tightly regulated by an array of enzymatic
and non-enzymatic ways to keep redox balance. This balance in
humans is maintained by a well-balanced antioxidant system that
is responsible for homeostatic balance, which maintains phys-
iologic functions but prevents oxidative damage. Antioxidants,
in general, are substances that decrease the severity of OS by
forming less active radicals or by quenching damage created by
free-radical chain reactions. They can slow down or prevent dam-
age to body cells and lower the risk of infection by improving
immune function. Antioxidants can be classified into three major
categories: (1) low molecular antioxidants [glutathione (GSH),
vitamins C and E, bilirubin, and urate], (2) enzymes that neu-
tralize free radicals [superoxide-dismutase, catalase, glutathione
peroxidase (GPx), DT diaphorase, and peroxiredoxin], and (3)
non-enzymatic proteins (thioredoxin, glutaredoxin, and metl-
lothionines). Antioxidants can also be classified as primary and
secondary. Primary antioxidants are endogenous enzymes [e.g.,
super oxide dismutase (SOD), catalase, and GPx] acting at the
site where free radicals are formed. Secondary antioxidants are
exogenous molecules obtained through food (e.g., Vitamins A,
C, E, carotenoids). As detailed in Table 1, regardless of primary
or secondary, endogenous or exogenous status, antioxidants have
specific functions.
WHY ANTIOXIDANT SUPPLEMENTATION FAILS IN
PREVENTING ADVERSE PREGNANCY OUTCOMES?
A healthy pregnancy is characterized by a stable balance between
ROS and antioxidants (46, 47, 49). Redox imbalance is an under-
lying pathologic feature of many pregnancy complications. All
of the PTB and pROM risk factors detailed above are capable of
causing redox imbalance, leading to the production of superox-
ide, hydrogen peroxide, hydroxyl ions, and nitric oxide that can
Table 1 | Antioxidants and their potential roles associated with
reactive oxygen species (ROS) mediated damage.
Antioxidants Potential role
Super oxide dismutase (SOD) Direct protection against ROS
Glutathione peroxidase (GPx)
Catalase (Cat)
Peroxiredoxin
Glutathione Non-specific reduction
Vitamin C
Vitamin E Protection against lipid peroxidation
β-Carotene
Transferrin Metal sequestration
Lactoferrin
Ferritin
Metallothionein (MT)
DNA repair enzymes Repair enzymes
Macroxyproteinases
Glutathione transferase (GST)
Thioredoxins (Trx)
damage collagen matrix and consume antioxidant defenses. These
events can trigger uterine contractions (labor), leading to PTB.
Based on this imbalance theory, antioxidant clinical trials have
been primarily carried out to compensate for deficiencies and to
maintain redox balances. However, these trials expected to reduce
OS and improve pregnancy outcomes have met with minimal suc-
cess (36, 57–61). Numerous reasons can be cited for the failure of
these trials, but the following primary factors are highlighted:
1. OS-induced tissue injury or damage is the likely pathology
and trigger of several downstream effects like initiation of
labor or membrane rupture. OS damage generates a vicious
cycle of events (enhanced inflammation, cell death, and tis-
sue destruction), and antioxidants do not regulate these events
and are unlikely to impact OS damage. Therefore, it is unlikely
that reversing OS through antioxidant supplementation would
reduce the risk of adverse pregnancy outcomes.
2. Clinical trials are conducted based on the generalized theory
that OS is an underlying pathology. This theory is unlikely; this
may be the case for a limited subset of subjects with specific
exposures with ROS as an initiator of downstream events.
3. Biomarker screenings for ROS are not done prior to interven-
tion to determine the type of ROS or to assess the amount
of ROS-associated damage. Even the type of biomarker mea-
sures may not be reflective of risk exposure or the extent of ROS
because these biomarkers may represent an end stage indicative
of tissue damage and not necessarily risk.
4. Like inflammation, ROS is not a homogeneous phenomenon.
Different tissues and cells, cytoplasmic and nuclear membranes,
and the contents of different organelles (inner and outer mem-
branes of mitochondria) may react differently to various stres-
sors, producing distinct patterns of ROS. The antioxidants used
in trials may curtail a particular ROS pathway or production of
a specific free radical, but depending on the type of risk factor
(e.g., cigarette smoke vs. poor nutrition), the ROS pathway and
antioxidant requirement may be different.
5. Reactive oxygen species-associated damage can be any of the
major functional elements mentioned earlier, and the degree
of damage is likely dependent on the site, risk factors, and types
of triggers that initiate an ROS-mediated response.
AMBIGUITY IN ANTIOXIDANT AND OS DAMAGE MARKER
ANALYSIS
Many studies have reported antioxidant deficiencies as a causal fac-
tor associated with adverse pregnancy outcomes. In the wake of a
failed antioxidant supplementation trial, my laboratory conducted
a cross-sectional study examining two antioxidant enzymes (SOD1
and catalase) and two OS damage markers (F2-Isoprostane – lipid
peroxidation product – and 8-OxodG – DNA damage). Banked
maternal plasma samples were collected from subjects at the time
of delivery admission for either a term labor (n= 19), preterm
labor (n= 18), or pPROM (n= 13). An ELISA-based analysis was
performed using these samples. If each of the markers is analyzed
independently, multitudes of interpretations can be derived. For
example, if SOD was the only analyte tested, as shown in Figure 3A,
SOD was higher at term and reduced significantly in PTB and
pPROM. These data are normally interpreted as heightened OS at
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FIGURE 3 | Maternal plasma levels of two antioxidants super oxide
dismutase (SOD) and catalase and two OS markers, 8-oxodG and
F2-Isoprostanes. (A) Antioxidant enzyme Super oxide dismutase
concentrations. (B) Antioxidant enzyme catalase concentrations.
(C) Lipid peroxidation product F2-Isoprostane concentration. (D) bDNA
oxidation product 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxodG)
concentration. *P <0.05 compared to term birth; #P <0.05 compared
to PTB.
pPROM, followed by PTB, and none at term birth. If catalase was
the only marker analyzed using the same samples (Figure 3B),
term birth has the highest OS, followed by PTB, and none at
pPROM, which highlights the ambiguity associated with singe
marker analysis of OS. Even examining the two enzymes together
only provides conflicting data regarding OS during pregnancy.
This interpretation did not take metabolic demands, prooxidant
levels, the status of other antioxidants, or existing damage due to
ongoing OS into consideration. It is important to note that mea-
surement of OS in biological fluids may not be a true reflection
of cellular level OS as it is difficult to measure. Redox balance is
a coordinated function of multitudes of molecules, and examin-
ing antioxidants alone may not be sufficient to gage the intensity
of OS. However, examining the OS-induced damage can generate
better conclusions regarding OS than examining antioxidant lev-
els alone. Figures 3C,D demonstrates the evidence for OS-induced
generation of DNA and lipid peroxidation products (8-OxodG and
F2-Isoprostanes, respectively). Our analysis showed that maternal
plasma OS damage is higher in pPROMs than in both normal term
births and PTBs. To note, the damages are minimal at term birth
although labor and delivery are documented to have higher OS. It
is expected that at term labor and delivery the metabolic demands
are very high, and mature fetuses and fetal tissues of the intra
uterine cavity generate OS and OS-induced signals from cellular
damages. However, at term, a normal physiologic redox balance
is fully functional and thus minimizes the OS-induced damage
to cellular elements. Risk-induced OS and overwhelming dam-
age generated signals are unlikely to be controlled by cellular or
organ-level antioxidant capacity, leading to premature activation
of signals for PTB or pPROM.
CAN OS DAMAGE LEAD TO ADVERSE PREGNANCY
OUTCOMES?
Oxidative stress and OS-induced damage can produce a spectrum
of genetic, metabolic, and cellular responses, and prooxidants exert
their effects on cellular elements – namely lipids, proteins, and
nucleic acids – disrupting their expression, structure, and func-
tion (46, 54, 62). Peroxidation of proteins leads to the loss of
the sulfhydryl groups and linking of carbonyl groups with the
side chains of other amino acids (63, 64). Although these pro-
teins are normally proteolytically cleared from the system, under
heightened ROS, oxidized proteins do not undergo proteolysis
but rather accumulate as long hydrophobic bonds that affect cell
function (63).
Cell membrane phospholipids are always a target of ROS activ-
ity (48). The peroxidized cell membrane stiffens, loses its selective
permeability, and loses its integrity. Oxidized cell membranes are
also susceptible to action by phospholipase enzymes that can
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activate a series of enzymatic and non-enzymatic breakdowns of
oxidized phospholipids. One of the non-enzymatic by-products
of this lipid peroxidation is F2-Isoprostane, which is considered
the biomarker of ROS (65).
Reactive oxygen species causes the most lethal damage on DNA.
This damage can result in single- or double-strand breaks, inter-
changing of sister chromatids, crosslinking of DNA to DNA or
protein, or base modifications (66–68). Although all four bases of
DNA are susceptible to ROS-mediated alterations, hydroxylated
nucleotide 8-hydroxy-deoxyguanine (8-OHdG) was for the first
time referred to as a major product of oxidative DNA damage (see
Glossary), and high concentrations of 8-OHdG in biological fluids
are considered a biomarker of ROS (69–80). Damages in DNA are
constantly repaired, and simply measuring 8-OHdG levels is not
sufficient to measure the extent of ROS; however, higher concen-
trations of 8-OHdG clearly indicate an underlying pathology that
cannot be ignored.
DOCUMENTATION OF OS DAMAGE IN PTB, pPROM, AND
NORMAL TERM BIRTH
This section of the review explains some of the ongoing basic
research studies designed to address OS-induced damages and how
they differentially associate with PTB, pPROM, and normal term
birth (81, 82). Briefly, we examined amniotic fluid samples for OS
markers (lipid peroxidation – F2-Isoprostanes) and OS-induced 3-
nitrotyrosine modified proteins (3-NT) in fetal membranes from
PTB, pPROM, and term birth. Both PTB and pPROM had higher
amniotic fluid F2-Isoprostanes than term birth. Cigarette smok-
ing during pregnancy was associated with higher F2-Isoprostanes,
regardless of pregnancy outcomes, and infection (in PTB). It was
also associated with higher F2-Isoprostanes, compared to PTB
with no infection. 3-NT staining, a marker of protein modifi-
cation by OS, was more similar between term birth and pPROM
than PTB.
In an earlier study, we reported changes associated with telom-
ere length, a marker of aging, and OS. Telomeres are DNA–protein
complexes, consisting of 5–15 kbp of repetitive DNA sequences,
located at the ends of the chromosomes. They are essential for
chromosome stability and cell survival, protecting them from end-
to-end fusion and degradation. With each cell division, telomeres
are shortened, and once a critical shortening is attained, division
cycles halt and cell senescence (see Glossary) is triggered. Thus,
telomere lengths serve as a valid marker of a cell’s biologic age. OS
can induce single and double DNA strand breaks, which are detri-
mental to telomere shortening. Therefore, telomere shortening can
be caused by natural aging or pathologically induced premature
aging due to OS.
Interestingly, telomeres are shorter in early pPROM
(<34 weeks) than in gestational age-matched PTB with intact
membranes. However, telomere lengths are similar between early
pPROMs and term births (>40 weeks), and it is suggestive of a
similarity between the two phenotypes of pregnancy (83). Several
such similarities in molecular and histologic markers exist between
pPROM and normal term birth that lead us to hypothesize that
pPROM may have early aging fetal tissues that may be prompting
rupture and delivery.
We have examined likely causes and mechanisms of telomere
shortening in fetal tissues. The next sections of this review will
describe how OS-induced damages and tissue level changes may
generate signals of parturition during normal pregnancies and
how they may be pathologic in pPROM and a subset of PTB.
OS-INDUCED DNA DAMAGE AND ITS CONSEQUENCES
As detailed in previous sections, OS causes changes in DNA
bases, especially Guanine. We have tested the generation of 8-
OxoG formation in fetal amnion cells in response to OS. Figure 4
provides experimental evidence for DNA damage and its likely
consequences. The OS response was induced in laboratory con-
ditions using water soluble cigarette smoke extract (CSE) that is
a known OS producer and a well-known risk factor of adverse
pregnancy outcomes. Primary amnion cells obtained from pla-
centas from normal term births, not Cesarean births, were used
for this study (84). When exposed to CSE, amnion cells produced
ROS (Figure 4A). This ROS production was down-regulated by
antioxidant N-acetyl cysteine treatment, confirming OS produc-
tion by amniocytes. These amnion cells also demonstrated signif-
icant DNA damage (Figure 4B), and the DNA lesions contained
8-OxoG (Figure 4C). High 8-OxoG levels may explain the short-
ened telomere length observed in a prior report, as these repetitive
sequences are guanine rich and susceptible to ROS (83). To ver-
ify the shortening of telomeres, we treated the cells with CSE.
CSE-induced telomere reduction was visible after 96 h compared
to untreated controls, confirming that OS-inducing risk factors
may cause oxidation of DNA that can lead to telomere attrition
(Figure 4D). Telomere uncapping occurs when cells have criti-
cally shortened telomeres or when telomere-protective factors are
impaired (85). Loss of telomere function can induce cell cycle
arrest and senescence. One of the consequences of DNA dam-
age and telomere attrition is also formation of DNA damage foci
(DDF) in cells.
We have also analyzed the consequences of DNA damage and
telomere attrition in amnion cells. DNA damage is a regular event
during growth, and it is precisely fixed or repaired by multitudes
of DNA repair mechanisms (86–92). However, persistent DNA
damage in response to overwhelming OS or in response to OS-
inducing risk factors, as often seen during adverse pregnancies,
causes DNA breaks followed by the phosphorylation of the his-
tone H2AX, which is a variant of the H2A protein family known
as γ-H2AX. Analysis of amnion cells that lost telomere fragments
after exposure to CSE revealed generation of DDF (Figure 4E).
Signals arising from cells with DDF will eventually determine the
fate of the affected cell through multitudes of pathways activat-
ing several cell cycle regulatory molecules (93–97). Analysis of
multiple cell cycle regulatory factors revealed activation of p38
mitogen activated protein kinase pathway (p38MAPK) in amnion
cells in response to CSE exposure (Figure 4F). p38MAPK activa-
tion by phosphorylation of its catalytic site residues, threonine-180
and tyrosine-182, promotes cell cycle arrest and cellular senes-
cence by targeting the expression of proteins of SP (Figure 4G)
(98, 99). Activation of p38MAPK to phosphorylated p38MAPK
(pp38MAPK) by SP was prevented by antioxidant NAC confirm-
ing the influence of OS in p38MAPK activation. It is interesting to
note that we did not see activation of another pro-senescence pro-
tein p53 in amnion cells treated with CSE although this has been
reported in maternal decidual cells in animal models of pregnancy
by SK Dey’s group.
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FIGURE 4 | Proposed pathways of senescence activation in human
amnion primary epithelial cell cultures. (A) Amnion cell cultures
established from normal term Cesarean section placental membranes
(cytokeratin stained) were exposed to cigarette smoke extract (CSE), and
reactive oxygen species (ROS) generation was measured. ROS kinetics were
monitored using 2′-, 7′-dichlorodihydrofluorescein diacetate (H2DCFDA) as an
indicator for ROS in cells. Changes in DCF fluorescence were expressed as
arbitrary fluorescence units. CSE-induced ROS generation was inhibited by
N-acetyl cysteine. LPS also induced ROS but at a much lower level than CSE.
(B) We performed two separate experiments to document: (1) DNA damage
(Comet assay-silver staining) and (2) 8-OxoG production (FLARE) in amnion
cells for Comet and FLARE. Amnion cells were harvested after treatment with
CSE and immobilized in a layer of low melting point agarose on the FLARE
slide. We demonstrated Comet formation after CSE treatment of amnion
cells, confirming DNA damage with CSE. (C) Fragment length analysis using
repair enzyme (FLARE) assays showed a similar Comet formation that
confirmed 8-oxoG production, one of the most lethal biomarkers, in response
to CSE, indicating 8-oxoG:OGG1 complex activity. (D) Exposure of these cells
to ROS (by CSE) led to reduction of telomere length (P <0.05), confirming a
similar observation reported in fetal membranes from pPROM. (E) Telomere
reduction by ROS can cause DNA damage foci (DDF) formation, indicating
chronic OS damage. Amnion cells showed phosphorylated histone B protein
(g-H2AX). (F) These amnion cells exposed to CSE also demonstrated a
time-dependent activation of p38MAPK that persisted for 96 h. This activation
was inhibited by NAC, confirming ROS-mediated effect. (G) p38MAPK (a
pro-senescence protein) caused development of senescence-specific
b-galactosidase staining in cells, confirming senescence of amnion epithelial
cells after CSE exposure. Senescence development led to the production of
one of the cytokines associated with senescence-associated secretory
phenotype (SASP). (H) We confirmed that this is a SASP or p38-mediated
effect when IL-8 was down-regulated after treating amnion cells with CSE and
p38MAPK inhibitor (SB203580).
ACTIVATION OF SENESCENCE IN FETAL CELLS BY p38MAPK
p38 Mitogen activated kinase is a pluripotent molecule and one of
its functions is to activate senescence (aging) of the cell. Senescence
is characterized by irreversible arrest of cell growth (99–103). Irre-
versible growth arrest at the G1 phase of the cell cycle is a major
characteristic of senescence. Unlike apoptosis, these cells persist,
alter their function, and change the tissue environment, inducing
a unique signature of inflammatory markers similar to those seen
in PTB and pPROM (104, 105). The amniochorionic cells divide at
a rapid rate throughout gestation to accommodate the increasing
demands of the intrauterine contents. This proliferative activity is
a normal process that is expected to continue even at term (106).
Overwhelming OS forces cells to undergo transformation either
as malignant or senescence (107). Hostile pregnancy environ-
ments promote senescence of membrane cells and activation of an
inflammatory condition that we propose causes adverse pregnancy
outcomes as seen predominantly in early pPROM and a subset
of PTBs complicated by chronic OS. We were able to document
senescence of amniotic cells exposed to CSE using senescence-
associated β-Galactosidase (SA-β-Gal) staining (Figure 4G). The
number of SA-β-Gal positive cells was significantly higher after
CSE treatment than untreated control amnion cells, confirming
the development of senescence phenotype. Morphologic exami-
nation using transmission electron microscopy revealed features of
senescence in fetal membrane cells, characterized by enlarged cells
with senescence-associated heterochromatic foci, enlargement of
organelles, and particularly endoplasmic reticulum and mito-
chondria. Senescing cells are also reported to produce a unique
inflammatory signature known as senescence-associated secretory
phenotype (SASP) (see Glossary) (104, 108, 109). SASP markers
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include cytokines, chemokines, growth factors, angiogenic factors,
MMPs, and tissue inhibitors of matrix degrading enzymes, adhe-
sion molecules, receptors, and receptor antagonists. Many SASP
factors are reported as inflammatory mediators of pregnancies,
and therefore it is not surprising to see more of them during
preterm and term labors. Treatment of amnion cells with CSE
and p38MAPK inhibitors (SB203580) substantially reduced IL-8
to the level of controls (Figure 4H). IL-8 generation as a part of
CSE treatment and controlling its production through p38MAPK
pathways suggests that the inflammatory process associated with
term labors, preterm labors, and pPROMs can also arise in the
absence of infections, and it is likely generated by senescing cells
of the placenta and fetal membranes. Based on these findings and
ongoing research in the laboratory, I propose that the source of
inflammation is not just invading immunocytes, but it is likely
that senescing fetal cells generate signals of parturition at term.
In pPROM or PTB, a pathologic trigger resulting in OS can cause
premature fetal cell senescence and SASP signaling onset of labor
or cause rupture.
DIFFERENCES BETWEEN PTB AND pPROM; CAN OS
DETERMINE OUTCOMES?
As described in previous sections, there are several similarities
between early pROM and term birth. Similarly, several salient
differences exist between PTB and pPROM although they have
epidemiological and clinical similarities. Many of the similarities
and differences are listed in Table 2. Inflammation is an underlying
factor in PTB and pPROM; however, the extent of OS damage may
be higher in pPROM, especially those that are early (<34 weeks of
gestation). OS and inflammation are inseparable events, and bio-
markers executing these responses are linked. It is also important
to note that PTB is not devoid of any of the markers or indica-
tions listed in Table 2. In comparison with pPROM, the degree
of OS and proteolysis seems to be more minimal in PTB than in
pPROM. These findings are limited to early PTB and pPROM.
Data are more inconclusive in cases between 34 and 37 weeks of
gestation, late PTB, and pPROM. Based on the data used in in vitro
models and in situ findings, pPROM seems to result from chronic
OS whereas PTB results from acute OS. Chronic and overwhelm-
ing OS can cause telomere attrition, DDF formation, p38MAPK
activation, fetal cell senescence, and SASP whereas acute OS may
be sustainable by cells’ ability to resist OS-induced damages but
still develop an inflammatory environment that is different than
SASP. The former is expected to cause pPROM, and the latter
may likely lead to PTB. In light of this evidence, it is also pos-
sible that infection is not the causal factor for a large subset of
pPROMs and PTBs. Non-infectious cellular atrophies due to OS or
OS-induced senescence cause sterile inflammation that can gener-
ate an immunocompromised intrauterine setting. A recent report
by Romero et al. supports the concept of sterile intra-amniotic
inflammation (110). When a sterile inflammatory milieu is cre-
ated, it may provide an ideal environment for microbial invasion
or activation of resident microbial flora in which case infection is
likely secondary to an underlying pathology.
The delineation of PTB and pPROM pathways depends on sev-
eral factors and are not limited to the: (1) type and load of risk
factors, (2) antioxidant status of subject, (3) gestational age, (4)
Table 2 | Markers studied in various maternal–fetal compartments and
their similarities and differences between PTB with intact membranes
and preterm premature rupture of the membranes (pPROM).
Biomarker Sample Indication pPROM vs. PTB
F2-IsoP Amniotic fluid Oxidative
stress
Higher in pPROM
3-NT staining Fetal membranes Oxidative
stress
Higher in pPROM
Salivary
proteases
Maternal saliva Proteolysis Higher in pPROM
MMPs/TIMPs Amniotic fluid Proteolysis Higher in pPROM
Cytokines (IL-1,
TNF, IL-6, IL-8)
Amniotic fluid Inflammation No difference
Telomere length Fetal DNA and
fetal membranes
Senescence Higher in PTB
p38MAPK Fetal membranes Senescence Higher in pPROM
p53 Fetal membranes Senescence Higher in pPROM
8-OxodG Maternal plasma DNA
damage
Higher in pPROM
8-Oxoguanine
glycosylase
(OGG1)
Fetal membranes DNA
damage
repair
Higher in PTB
Ras-GTPase Fetal membranes Intracellular
signaling
Higher in PTB
Fas/Fas L Fetal membranes Apoptosis Higher in pPROM
overall immune status of the individual, or (5) genetic, epigenetic,
and other socio-demographic factors. Based on the data described
above, a new model of PTB and pPROM delineating pathways
are described in Figure 5. These cases can be divided into subsets
based on OS/inflammation and OS/inflammation-induced dam-
ages; therefore, overlap between subsets are expected and rupture
or lack of rupture in PTB may depend on an individual’s profile as
listed in the above paragraph. OS-induced DNA damage can cause
telomere uncapping; however, depending on the strength of ROS
and redox imbalance, pathways can arise in a telomere-dependent
and independent way. Telomere-dependent pathways will result
if base excision repair mechanisms fail to restore the damaged
segments and the cells proceed to undergo cell cycle arrest and
eventual cell death. Data from our laboratory demonstrate classic
signs of telomere attrition and telomere damage-induced changes
(8-oxoG accumulation, γ-H2AX, and nuclear membrane struc-
ture related Lamin B loss) in pPROM membranes or in amniotic
fluid (data not shown). Many of these factors are either minimal
or non-existent in a majority of PTB cases. Telomere-independent
pathways can arise where DNA damage is minimal or where base
excision repair mechanisms are functional and able to rebuild the
damaged segments. During this process, 8-OxoG generated due to
oxidative damage of telomere segments or G bases in other parts
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FIGURE 5 | Oxidative stress-induced pathways of pPROM and
spontaneous PTB with intact membranes. Risk factors of pPROM and
PTB – like infection, obesity, poor nutrition, stress, behavioral risk factors
(cigarette smoking, drinking, and drug abuse) – can cause oxidative stress
(OS) in human fetal membranes that leads to OS-induced damages to all
major cellular elements (lipids, proteins, and nucleic acid). Damages to DNA
are especially lethal to fetal membranes and placental cells because they lead
to oxidation of guanine base, resulting in mutagenic 8-OxoG formation.
Telomeres are rich in G bases, and oxidation G bases lead to telomere attrition
as a part of damage repair [base excision repair (BER)]. The pathway of
pPROM and PTB may be delineated at this stage based on the type of risk
and the type of OS response: overwhelming OS (chronic OS with smoking,
alcohol use, obesity, poor nutrition, etc.) vs. infection/inflammation-related
acute OS by fetal cells or immunocytes. Overwhelming OS can lead to
persistent DNA damage and telomere reduction, 8-OxoG formation, resulting
in DNA damage foci (DDF) formation. Telomere-dependent pathway – when
OS is too high to be controlled by antioxidant mechanisms of the intrauterine
tissues, especially fetal membranes, a telomere-dependent pathway arises
where either OS itself or damaged DNA and other cellular elements can
trigger p38MAPK activation either through NF-κB activation or direct cellular
senescence. This is characterized by rounded, swollen organelles, and nuclear
condensates. Additionally, senescing cells generate a unique set of
biomarkers (senescence-associated secretory phenotype – SASP). SASP is
characterized by cytokines, chemokines, matrix metalloproteinases, growth
and angiogenic factors, and eicosanoids, all of which are involved in
promoting labor. Telomere-independent pathway – in this pathway, oxidized
Gs are excised from the damaged region by 8-oxoguanine glycosylase (OGG1)
as a part of BER. 8-OxoG:OGG1 complex then activates Ras-GTPase and
either promotes p53-mediated apoptosis or NF-κB-mediated inflammation.
The exact mechanism of this switch is still unclear. Apoptosis is previously
linked to pPROM. The latter pathway of NF-κB-mediated inflammation can be
linked mostly to PTB with intact membranes.
of DNA are repaired by a specific enzyme called 8-Oxoguanine
glycosylase (OGG1) (88, 111–113). Recent findings suggest that 8-
OxoG:OGG1 complex can cause Ras-GTPase activation, resulting
in inflammation (114–116). Fetal membrane analysis of OGG1
mRNA expression also revealed more OGG1 in PTB than in
pPROM, suggesting that DNA repair is more active in PTB than
in pPROM due reduced availability of OGG1 (117). In unpub-
lished findings, we also noticed higher Ras-GTPase activation in
fetal membranes from PTB than pPROM. Although we have not
confirmed this descriptive data through mechanistic studies, it is
also possible that telomere-independent activation of DNA dam-
age repair may cause two separate events as shown on the right
side of Figure 5.
8-OxoG:OGG1 complex (DNA damage repair) can cause Ras-
GTPase activation culminating in either antitumor p53 (proapop-
totic) activation, resulting in pPROM, or culminating in master
transcriptional factor NF-κB activation, resulting in inflamma-
tion without apoptosis. Earlier reports have shown evidence of
apoptosis in fetal membranes from pPROMs through p53 path-
ways (118–123). Therefore, it is likely that both apoptosis and
senescence may be seen in pPROM and will be a subset (based on
exposure and host response). It is also important to note that we
did not document active p53 in membranes from pPROM in our
studies reported a decade ago. However, we did see effector caspase
activation suggesting that apoptosis and senescence may both have
independent roles in pPROM outcomes. NF-κB activation and
its contribution are well reported by several investigators (124–
130). NF-κB activation can occur by multitudes of risk factors’
specific signaling routes in PTB and pPROM or by maternal–fetal
endocrine signals of initiation of parturition at term. DNA damage
repair associated signals may also cause NF-κB activation resulting
in PTB and pPROM, but this is not a well-studied mechanism in
PTB and pPROM.
CAN FETAL CELL SENESCENCE TRIGGER TERM BIRTH?
Senescence of fetal membrane cells are very pronounced in term
(>40 weeks) deliveries but not in term Cesarean sections when the
patient is not in labor. Fetal membranes and placentas experience
considerable OS at term prior to initiation of labor, which can
lead to p38MAPK activation similar to that seen in pPROM mem-
branes, causing senescence and further enhancement of SP and
SASP. Fetally derived SASP factors are signals of maturation and
can promote labor at term. The inflammatory milieu observed at
term is of non-infectious origin, and senescence/SASP is likely one
of the factors contributing to this phenomenon. Ongoing work in
our research laboratories will further elucidate this mechanism,
and understanding this phenomenon will improve our knowledge
of the labor process and likely allow us to develop screening and
diagnostic markers and identify intervention targets based on OS
leading to p38MAPK and senescence.
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SUMMARY
Oxidative stress is an inevitable component of pregnancy, and it
is tightly regulated until labor and delivery. OS build-up at term
due to an increasing demand from the fetus and heightened phys-
iologic stress promotes senescence. Fetal tissues, placentas, and
maturing fetuses generate signals of aging prompting labor and
delivery. These signals we report here as SASP are mediators of
uterotonic activities. These SASP signals may very well be regu-
lated or influenced or in tandem with already reported biologic,
endocrine regulated mechanisms of labor triggers (131–135). Risk
factors of adverse pregnancies may cause premature aging of fetal
tissues, triggering pathological mechanisms (specifically pPROM
and in a subset of PTB with high OS damage as demonstrated
by our data) that may result in premature activation of labor
and/or rupture of the membranes. Reduction of adverse outcomes
requires better characterization of biomolecules and pathways to
understand their precise roles in triggering premature aging.
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GLOSSARY
OXIDATIVE DAMAGE
Reactive oxygen species generated due to various physiologic and
pathologic processes can lead to damage of major cellular ele-
ments, including DNA, RNA, proteins, and lipids, causing dys-
functional molecules that impact cellular integrity. Oxidative stress
damage is associated with several disease processes and is also seen
in the natural aging process.
OXIDATIVE DNA DAMAGE
Reactive oxygen species often target the DNA and cause
oxidatively damaged DNA base lesions. Guanine is most
prone to have oxidative damages, primarily 8-oxo-7, 8-
dihydroguanine (8-oxoG). Telomeres, the chromosomal pro-
tective caps, are rich in Guanine bases, and they succumb
to oxidative damage. Telomere attrition, seen in certain preg-
nancy complications, denotes oxidative stress during pregnancy
complications.
SENESCENCE
Senescence or biologic aging involves the phenomenon of irre-
versible arrest of cell growth. Unlike apoptosis, these cells persist,
alter their function, and change the tissue environment, inducing
a unique signature of inflammatory markers. Placental and fetal
tissues at term experience intensified oxidative stress and cellu-
lar damage, resulting in senescence. Senescent fetal cells can be
considered as fetal signals of maturation to initiate labor.
SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE
Cells undergoing senescence produce a distinctive tissue microen-
vironment that transforms these cells into inflammatory cells
characterized unique biochemical markers. These markers include
cytokines, chemokines, growth and angiogenic factors, matrix
degrading enzymes, and inhibitors among other classes of pro-
teins. Fetal cell senescence can cause senescence-associated secre-
tory phenotype (SASP) production with uterotonic properties and
acts as signals of labor initiation.
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